137 related articles for article (PubMed ID: 32643975)
1. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
2. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
[TBL] [Abstract][Full Text] [Related]
3. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
5. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO
Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917
[TBL] [Abstract][Full Text] [Related]
6. Dacryoadenitis associated with adenoviral keratoconjunctivitis.
Amjadi S; Rajak S; Solanki H; Selva D
Clin Exp Ophthalmol; 2016 Mar; 44(2):140-2. PubMed ID: 26302257
[No Abstract] [Full Text] [Related]
7. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Jeng BH; Holsclaw DS
Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
[TBL] [Abstract][Full Text] [Related]
9. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
[TBL] [Abstract][Full Text] [Related]
10. [Ganciclovir 0.15% ophthalmic gel in the treatment of adenovirus keratoconjunctivitis].
Yabiku ST; Yabiku MM; Bottós KM; Araújo AL; Freitas Dd; Belfort R
Arq Bras Oftalmol; 2011; 74(6):417-21. PubMed ID: 22331114
[TBL] [Abstract][Full Text] [Related]
11. [Express diagnosis of eye adenovirus infection by fluorescent antibody method].
Kasparova EA; Marchenko NR; Loseva IE
Vestn Oftalmol; 1998; 114(4):24-6. PubMed ID: 9771083
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
Ghanem RC; Vargas JF; Ghanem VC
Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
[TBL] [Abstract][Full Text] [Related]
13. In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis.
Aydamirov AS; Harbiyeli II; Ozturk G; Yarkin F; Erdem E; Yagmur M
Int Ophthalmol; 2023 May; 43(5):1701-1710. PubMed ID: 36346478
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
Schuhman G; Vidic B
J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
[TBL] [Abstract][Full Text] [Related]
15. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis.
Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P
J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529
[TBL] [Abstract][Full Text] [Related]
16. Correlation between corneal involvement and anterior chamber flare in epidemic keratoconjunctivitis.
Kiyat P; Palamar M; Yilmaz SG; Emre S
Eur J Ophthalmol; 2020 Sep; 30(5):897-900. PubMed ID: 31111724
[TBL] [Abstract][Full Text] [Related]
17. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF
Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319
[TBL] [Abstract][Full Text] [Related]
18. Coexistent adenoviral keratoconjunctivitis and Acanthamoeba keratitis.
Gajdatsy AD; Kosmin A; Barrett GD
Clin Exp Ophthalmol; 2000 Dec; 28(6):434-6. PubMed ID: 11202467
[TBL] [Abstract][Full Text] [Related]
19. Reactivation of presumed adenoviral keratitis after laser in situ keratomileusis.
Safak N; Bilgihan K; Gürelik G; Ozdek S; Hasanreisoğlu B
J Cataract Refract Surg; 2002 Apr; 28(4):725-7. PubMed ID: 11955922
[TBL] [Abstract][Full Text] [Related]
20. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
Özen Tunay Z; Ozdemir O; Petricli IS
Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
